Abiopharma

Axogen Announces Proposed Public Offering of Common Stock

Heeson Lee 🟢 acquired 8.9K shares of INCYTE CORP (INCY) Transaction Date: Jan 16, 2026 | Filing ID: 000002

CAGNONI PABLO J 🟢 acquired 28.5K shares (1 derivative) of INCYTE CORP (INCY) at $106.21 ($3.0M) Transaction Date: Jan 16, 2026 | Filing ID: 000002

Stein Steven H 🟢 acquired 19.9K shares (1 derivative) of INCYTE CORP (INCY) at $106.21 ($2.1M) Transaction Date: Jan 16, 2026 | Filing ID: 000006

Issa Mohamed Khairie 🟢 acquired 14.2K shares (1 derivative) of INCYTE CORP (INCY) at $106.21 ($1.5M) Transaction Date: Jan 16, 2026 | Filing ID: 000004

Robey Walter Wade 🔴 sold 693 shares of Oil-Dri Corp of America (ODC) at $56.04 Transaction Date: Jan 20, 2026 | Filing ID: 002871

(99% Neutral) enGene Inc (ENGNW) Announces Business Combination

Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)

Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call

Coherent Corp. Announces Timing of FY2026 Second Quarter Earnings Release

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast

Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

GRI Bio Announces Reverse Stock Split

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results